Collegium Pharmaceutical, Inc.
COLL
$28.23
$0.080.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.92M | 74.95M | 62.87M | 58.44M | 36.27M |
| Total Depreciation and Amortization | 233.60M | 225.45M | 226.07M | 226.19M | 211.43M |
| Total Amortization of Deferred Charges | 4.52M | 4.79M | 5.34M | 5.49M | 5.35M |
| Total Other Non-Cash Items | 28.80M | 30.24M | 31.28M | 14.06M | 19.14M |
| Change in Net Operating Assets | 15.08M | -4.39M | 3.76M | -13.26M | -68.71M |
| Cash from Operations | 329.92M | 331.04M | 329.32M | 290.92M | 203.48M |
| Capital Expenditure | -1.64M | -1.21M | -1.74M | -1.62M | -1.68M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -655.40M | -- | -- | 0.00 | -267.54M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 105.15M | -51.01M | -61.79M | -53.60M | -4.11M |
| Cash from Investing | -551.90M | -52.23M | -63.53M | -55.23M | -273.32M |
| Total Debt Issued | 864.68M | 565.18M | 565.18M | 11.83M | 325.00M |
| Total Debt Repaid | -617.77M | -626.66M | -635.56M | -64.58M | -213.06M |
| Issuance of Common Stock | 5.10M | 4.93M | 5.64M | 4.83M | 3.16M |
| Repurchase of Common Stock | -17.90M | -42.79M | -37.95M | -62.39M | -61.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -7.00M | -7.56M | -19.38M | -19.38M |
| Cash from Financing | 234.11M | -106.35M | -110.25M | -129.70M | 34.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.13M | 172.46M | 155.55M | 105.99M | -35.69M |